Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Barnett

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Vaccines|September 8, 2015
Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in SituYen Cu, Kate E Broderick, Kaustuv Banerjee, et al.
Vaccine|January 27, 2004
Neutralization of primary HIV-1 SF13 can be detected in extended incubation phase assays with sera from monkeys immunized with recombinant HIV-1 SF2 gp120David Davis, Helen Donners, Betty Willems, et al.
Journal of Virology|May 14, 2005
Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particlesSoumi Gupta, Ramesh Janani, Qian Bin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2011
Quaternary structures of HIV Env immunogen exhibit conformational vicissitudes and interface diminution elicited by ligand bindingCarlos G Moscoso, Yide Sun, Selina Poon, et al.
Plos One|September 17, 2009
Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxinDavid J M Lewis, Zhiming Huo, Susan Barnett, et al.
AIDS Research and Human Retroviruses|December 14, 2004
Mucosal and systemic anti-HIV responses in rhesus macaques following combinations of intranasal and parenteral immunizationsMichael Vajdy, Manmohan Singh, Jina Kazzaz, et al.
Vaccine|June 15, 2004
Enhancement of DNA vaccine potency in rhesus macaques by electroporationGillis Otten, Mary Schaefer, Barbara Doe, et al.
Vaccine|December 22, 2007
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDSRiccardo Gavioli, Silvia Cellini, Arianna Castaldello, et al.
Journal of Virology|March 25, 2011
Sequential immunization with a subtype B HIV-1 envelope quasispecies partially mimics the in vivo development of neutralizing antibodiesDelphine C Malherbe, Nicole A Doria-Rose, Lynda Misher, et al.
Science Translational Medicine|June 9, 2017
Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptakeFrank Liang, Gustaf Lindgren, Kerrie J Sandgren, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Vaccines|September 8, 2015
Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in SituYen Cu, Kate E Broderick, Kaustuv Banerjee, et al.
Vaccine|January 27, 2004
Neutralization of primary HIV-1 SF13 can be detected in extended incubation phase assays with sera from monkeys immunized with recombinant HIV-1 SF2 gp120David Davis, Helen Donners, Betty Willems, et al.
Journal of Virology|May 14, 2005
Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particlesSoumi Gupta, Ramesh Janani, Qian Bin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 30, 2011
Quaternary structures of HIV Env immunogen exhibit conformational vicissitudes and interface diminution elicited by ligand bindingCarlos G Moscoso, Yide Sun, Selina Poon, et al.
Plos One|September 17, 2009
Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxinDavid J M Lewis, Zhiming Huo, Susan Barnett, et al.
AIDS Research and Human Retroviruses|December 14, 2004
Mucosal and systemic anti-HIV responses in rhesus macaques following combinations of intranasal and parenteral immunizationsMichael Vajdy, Manmohan Singh, Jina Kazzaz, et al.
Vaccine|June 15, 2004
Enhancement of DNA vaccine potency in rhesus macaques by electroporationGillis Otten, Mary Schaefer, Barbara Doe, et al.
Vaccine|December 22, 2007
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDSRiccardo Gavioli, Silvia Cellini, Arianna Castaldello, et al.
Journal of Virology|March 25, 2011
Sequential immunization with a subtype B HIV-1 envelope quasispecies partially mimics the in vivo development of neutralizing antibodiesDelphine C Malherbe, Nicole A Doria-Rose, Lynda Misher, et al.
Science Translational Medicine|June 9, 2017
Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptakeFrank Liang, Gustaf Lindgren, Kerrie J Sandgren, et al.
Pageof 4